Creative Biolabs-Immuno-oncology

Anti-FLT1 (clone D1G6ZF7J) SynExpress T7-Cy3-cF-X Modified CD8+ T cells (CAT#: ITS-1224-CR382)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target FLT1 (clone D1G6ZF7J). We employs the Lentivirus (T7-Cy3-c-Fos-XbaI) vector components and the SynExpress system of the Histone modification sites Knockout/Balancing feedback for a robust and sustained response against cancers.
Host
Mouse
Target
FLT1
Clone
D1G6ZF7J
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
T7
Effector Gene
c-Fos
Insertion Sites
XbaI
Gene Modification
Knockout
Modification Domain
Histone modification sites
Carrier Type
Lentivirus
Transformation Accuracy
0.99
Cell Culture
Microcarrier Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.